Literature DB >> 11498045

TorsinA: movement at many levels.

X O Breakefield1, C Kamm, P I Hanson.   

Abstract

TorsinA is the causative protein in the human neurologic disease early onset torsin dystonia, a movement disorder involving dysfunction in the basal ganglia without apparent neurodegeneration. Most cases result from a dominantly acting three-base pair deletion in the TOR1A gene causing loss of a glutamic acid near the carboxyl terminus of torsinA. Torsins are members of the AAA(+) superfamily of ATPases and are present in all multicellular organisms. Initial studies suggest that torsinA is an ER protein involved in chaperone functions and/or membrane movement.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11498045     DOI: 10.1016/s0896-6273(01)00350-6

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  45 in total

1.  RNA interference-mediated inhibition of wild-type Torsin A expression increases apoptosis caused by oxidative stress in cultured cells.

Authors:  Xue-Ping Chen; Xiao-Hui Hu; Shu-Hui Wu; Yang-Wei Zhang; Bo Xiao; Hui-Fang Shang
Journal:  Neurochem Res       Date:  2010-05-09       Impact factor: 3.996

2.  Structure of the Golgi apparatus is not influenced by a GAG deletion mutation in the dystonia-associated gene Tor1a.

Authors:  Sara B Mitchell; Sadahiro Iwabuchi; Hiroyuki Kawano; Tsun Ming Tom Yuen; Jin-Young Koh; K W David Ho; N Charles Harata
Journal:  PLoS One       Date:  2018-11-07       Impact factor: 3.240

Review 3.  Recent advances in RNA interference therapeutics for CNS diseases.

Authors:  Pavitra S Ramachandran; Megan S Keiser; Beverly L Davidson
Journal:  Neurotherapeutics       Date:  2013-07       Impact factor: 7.620

4.  LINCing defective nuclear-cytoskeletal coupling and DYT1 dystonia.

Authors:  Cosmo A Saunders; G W Gant Luxton
Journal:  Cell Mol Bioeng       Date:  2016-02-03       Impact factor: 2.321

5.  Functional imaging in hereditary dystonia.

Authors:  M Carbon; M Argyelan; D Eidelberg
Journal:  Eur J Neurol       Date:  2010-07       Impact factor: 6.089

6.  Motor deficits and hyperactivity in Dyt1 knockdown mice.

Authors:  Mai T Dang; Fumiaki Yokoi; Morgan A Pence; Yuqing Li
Journal:  Neurosci Res       Date:  2006-10-13       Impact factor: 3.304

7.  Biochemical and cellular analysis of human variants of the DYT1 dystonia protein, TorsinA/TOR1A.

Authors:  Jasmin Hettich; Scott D Ryan; Osmar Norberto de Souza; Luís Fernando Saraiva Macedo Timmers; Shelun Tsai; Nadia A Atai; Cintia C da Hora; Xuan Zhang; Rashmi Kothary; Erik Snapp; Maria Ericsson; Kathrin Grundmann; Xandra O Breakefield; Flávia C Nery
Journal:  Hum Mutat       Date:  2014-07-17       Impact factor: 4.878

8.  Abnormal motor function and dopamine neurotransmission in DYT1 DeltaGAG transgenic mice.

Authors:  Yu Zhao; Michael DeCuypere; Mark S LeDoux
Journal:  Exp Neurol       Date:  2008-01-19       Impact factor: 5.330

9.  Characterization of human torsinA and its dystonia-associated mutant form.

Authors:  Zhonghua Liu; Anna Zolkiewska; Michal Zolkiewski
Journal:  Biochem J       Date:  2003-08-15       Impact factor: 3.857

10.  TorsinA in the nuclear envelope.

Authors:  Teresa V Naismith; John E Heuser; Xandra O Breakefield; Phyllis I Hanson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.